Introduction
Some plants are used worldwide for the treatment of various diseases. In Turkey, it is indicated that around 500 and that 200 kinds of plants have therapeutic potential. According to World Health Organization data, there are 1 900 herbal therapeutic agents in the world [1] . Considering the richness of the vegetation in our country, studies on widespread use of plants in treatment of diseases will be very beneficial in terms of economic returns.
Lichens are in a mutualistic life form formed by the combination of at least one fungus and photosynthetic green algae and/or cyanobacteria. In this symbiotic life form, algae provide water and mineral source for fungus photosynthesis, so the fungus can survive, grow and reproduce via photosynthesis products [2] .
Objective: To investigate the effects of atranorin, a lichen secondary metabolite, on SPC212 malignant mesothelioma cells in vitro. Methods: SPC212 malignant mesothelioma cell line was used. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay was used to evaluate cytotoxic effects of atranorin and cisplatin at 24, 48 and 72 h. Hematoxylin-eosin staining and 4',6-diamidino-2-phenylindole, dihydrochloride staining were used for determining cell and nucleus morphology, respectively. Wound healing assay was used for investigating cell migration. The xCELLigence real-time cell analysis system was used for determining cell proliferation. Results: Atranorin at 5-450 μM decreased cell viability at 24, 48 and 72 h. IC 50 values of atranorin were 300.94, 292.6 and 278.02 μM at 24, 48 and 72 h, respectively; meanwhile, the IC 50 values of cisplatin were 128.00, 34.37 and 17.05 μM at 24, 48 and 72 h, respectively. Furthermore, atranorin disrupted cell and nuclear morphology with increasing concentrations. Atranorin significantly reduced cell migration by 38%, 37% and 35% at 300, 250 and 200 μM, respectively (P<0.000). Atranorin at 160-450 μM decreased cell proliferation at 72 h (P<0.000). Conclusions: Atranorin has cytotoxic, antiproliferative, apoptotic and cell migration inhibitory effects on SPC212 malignant mesothelioma cancer cells.
Lichens are organisms spreading worldwide and there are many species in Turkey. They synthesize secondary metabolites to adapt to environment and living conditions. These metabolites are highly valuable. They cannot be isolated separately from each organism that forms the lichen, and can only be obtained from the whole lichen life form. These isolated secondary metabolites have been found to exhibit vasodilating, inhibitory, anti-inflammatory, antioxidant, anti-bacterial and cytotoxic effects on end-products of advanced glycation [3, 4] . More than one thousands of secondary metabolites have been isolated from lichens [5] . The most frequently studied lichen secondary metabolites are atranorin, physodic acid, (+)-usnic acid, (-)-usnic acid, vulpinic acid, gyrophoric acid, olivetoric acid, stictic acid and salazinic acid [5] .
Atranorin, a depsid derivative, is the most studied metabolite among all other secondary metabolites. Reports on anti-cancer properties of atranorin are increasing day by day. The effects of atranorin on melanoma, leukemia, colorectal, lung, prostate, breast, ovarian, and cervical cancers were investigated in vitro and promising results were obtained [6, 7] . According to our knowledge, there is a lack of studies on its effects on malignant mesothelioma, which is a very insidious and rapidly progressing cancer type.
Malignant mesothelioma is an aggressive cancer resulting from mesothelial cells that form the lining of body cavities, characterized by rapid progression, late metastasis and poor prognosis. Although it may originate from all body cavities, it is mostly seen in the pleura and peritoneum, and less frequently in the tunica vaginalis of the pericardium and testis [8] . In this study, SPC212 malignant pleural mesothelioma (MPM) cells were used. MPM is a common disease in Turkey due to environmental asbestos and erionite exposure, especially in Eskisehir, Nevsehir, and Diyarbakır in Turkey. It is estimated that 500-600 people every year in Turkey have been diagnosed as MPM [9] . The treatment is quite difficult and the survival rates are low. Therefore, there is a great need for new therapeutic agents and strategies.
The aim of this study was to investigate the effects of atranorin, a lichen secondary metabolite, on SPC212 MPM cells in vitro.
Materials and methods

Collection of plant material
Tepromela atra (Huds.) Hafellner was collected at Bozdağ Mountain, southwest of Tandır village, Eskişehir province in Turkey at 1 400 m on 10th of October 2018 and on siliceous rocks. Collected lichens were identified by using standard keys [10, 11] . Herbarium sample of the material is stored at the Herbarium of Eskisehir Technical University in the Department of Biology. 
Isolation and characterization of atranorin
Hematoxylin-eosin (H&E) staining
H&E staining was performed to examine cell morphology.
SPC212 cells seeded on sterile coverslips that were placed on sixwell plates were incubated in 5% CO 2 
4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) fluorescent staining
DAPI is a fluorescent dye that binds to DNA. SPC212 cells seeded on sterile coverslips that were placed on six-well plates were incubated in 5% CO 2 at 37 曟 for 24 h. The media was then removed and the cells were incubated for 24 h at different concentrations of atranorin (Untreated, 3, 160, 200, 250 and 300 μM of atranorin).
After 24 h, atranorin media was removed. At the end of the experiment, the cells adhered to the coverslips were fixed with 3.7%
formaldehyde solution in PBS for 15 min at 37 曟 . After fixation, the coverslips were washed 3 times with PBS. Cells were incubated with Triton-X 100 (0.2%) for 5 min and then washed 3 times with PBS.
After washing with PBS, the coverslips were incubated in the dark with 1 mg/mL DAPI at 37 曟 for 30 min. The coverslips were then washed with PBS and examined under fluorescence microscopy and photographed.
Cell migration assay
SPC212 cells were seeded into each well with equal numbers.
Cells were incubated to reach 90% confluency. The media was then 
Statistical analysis
All experiments were repeated 3 times. SPSS software (Statistics for Windows, Version 21.0, Armonk, New York, USA) was used to calculate the data. P values less than 0.05 were considered statistically significant. Shapiro-Wilk test was performed to examine whether the data were normally distributed. One-way ANOVA followed by Tukey's multiple comparison test were performed on normal dividing data.
Results
MTT results
After 24, 48 and 72 h, all concentrations of atranorin showed decreasing effect on the cell viability. After 24 h, atranorin at 100-450 μM significantly decreased the viability when compared to the control group (P<0.000). Cell viability was 6.7% at 450 μM ( 
H&E results
According to H&E staining data, in the control group and in the group treated with 3 μM of atranorin, the cell cytoplasm was eosinophilic and the nuclei were central and euchromatic, similarly.
Cell density in these two groups was higher than the other groups.
Atranorin at 3 μM did not change cell morphology. Atranorin caused an increased disruption of cell morphology at concentrations of 160, 200, 250 and 300 μM in a concentration-dependent manner.
It was also observed that the cells became smaller in size. Nucleus condensation was common in those groups (Figure 1 ). 
DAPI results
Nucleus morphologies were in round and equal sizes in the control group and in the group treated with 3 μM of atranorin. It was observed that atranorin disrupted the nucleus morphology and the nuclei were condensed and shrunk with increasing concentrations (Figure 2 ).
Cell migration assay results
The result showed that the cells migrated the wound area within 24 h in the control, 3 μM and 160 μM atranorin groups. Thus, it was indicated that concentrations of 3 μM and 160 μM of atranorin did not decrease cell migration. The concentrations of 200, 250 and 300 μM of atranorin significantly reduced cell migration by 35%, 37%
and 38%, respectively (P<0.000) (Figure 3 ).
xCELLigence real-time cell analysis system results
The effects of atranorin on cell proliferation were investigated by xCELLigence real-time cell analysis system. After 72 h, atranorin significantly decreased cell proliferation at the concentrations of 160-450 μM when compared to the control group (P<0.000). At 300-450 μM, the proliferation was gradually decreased to 0 after 72 h.
Atranorin had no effect on cell proliferation at 20-100 μM ( Figure   4A ).
After 72 h, cisplatin at all concentrations showed decreasing effect on the cell proliferation (P<0.000) ( Figure 4B ).
Discussion
This study has shown that atranorin, a lichen secondary metabolite, has cytotoxic, anti-proliferative, apoptotic and cell migration inhibitory effects on SPC212 malignant mesothelioma cells.
Although the anti-cancer and apoptotic effects of atranorin have been previously demonstrated in many cancers [6, 15] , the effects of atranorin on malignant mesothelioma cells have not been investigated up to this study. In this respect, this is an original study.
Many lichen acids can be isolated as secondary metabolites from lichens and each of them has different biological effects. Galanty et al. showed that usnic acid, a lichen acid, had a stronger anticarcinogenic effect on prostate and melanoma cells when compared to atranorin [15] . In our study, we used atranorin and mesothelioma in Jurkat leukemia cells [6] . In our study, the IC 50 value at 72 h was 278.02 μM, which is slightly higher than the results of Bačkorová and colony inhibitory effects on 4T1 breast cancer cells at 48 h [17] .
In our study, it was also observed that atranorin administration at 24 and 48 h had both cytotoxic effect and disruptive effect on cell nucleus. Russo et al. showed that 50 μM of atranorin significantly decreased cell viability in LNCaP and DU-145 prostate cancer cells at 72 h by 70% and 40%, respectively, when compared to control [18] . In our study, the cell viability decreased to 83.4% after and 200 mg/kg [19] . In our study, H&E staining showed that 3 μM of atranorin did not cause any change in cell morphology but increasing proapoptotic effects on many cancer types at 48 and 72 h via DAPI fluorescence staining [6] . Our study showed that nuclear morphology of atranorin-treated malignant mesothelioma cells was disrupted, condensed and shrunk at the doses of 160, 200, 250 and 300 μM via DAPI fluorescence staining. Nuclear condensation is regarded as one of the apoptosis indicators [20] . In this respect, it can be said that atranorin has shown apoptotic effects at high concentrations. condensation was observed in the group treated with 300 μM of atranorin also in our study. at a concentration of 5 μg/mL [23] . In our study, 3 and 160 μM of atranorin had no effect on cell migration and 200, 250 and 300 μM of atranorin reduced cell migration.
In conclusion, this study has been shown that atranorin has a cytotoxic, anti-proliferative, apoptotic and cell migration inhibitory effects on SPC212 malignant mesatelyoma cancer cells. New medicine and treatment approaches need to be developed for cancer and its treatment, which is the biggest medical problem of our time, and will be savior for the coming years. Secondary metabolites isolated from lichens have great potential to be new therapeutic agents. New and in-depth studies on these agents should be carried out.
